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Summary: Flavonoids are inactivated by phase II metabolism and occur in the body as glucuronides. Mam-
malian b-glucuronidase released from neutrophils at inflammatory sites may be able to deconjugate and thus
activate flavonoid glucuronides. We have studied deconjugation kinetics and pH optimum for four sources of
b-glucuronidase (human neutrophil, human recombinant, myeloid PLB-985 cells, Helix pomatia) with five
flavonoid glucuronides (quercetin-3-glucuronide, quercetin-3?-glucuronide, quercetin-4?-glucuronide, quer-
cetin-7-glucuronide, 3?-methylquercetin-3-glucuronide), 4-methylumbelliferyl-b-D-glucuronide, and para-
nitrophenol-glucuronide. All substrate-enzyme combinations tested exhibited first order kinetics. The opti-
mum pH for hydrolysis was between 3.5-5, with appreciable hydrolysis activities up to pH 5.5. At pH 4, the
Km ranged 44-fold from 22 mM for quercetin-4?-glucuronide with Helix pomatia b-glucuronidase, to 981 mM
for para-nitrophenol-glucuronide with recombinant b-glucuronidase. Vmax (range: 0.735-24.012 mmol
min－1unit－1 [1 unit is defined as the release of 1 mM 4-methylumbelliferyl-b-D-glucuronide per min]) and
the reaction rate constants at low substrate concentrations (k) (range: 0.002-0.062 min－1(unit/L)－1 were
similar for all substrates-enzyme combinations tested. In conclusion, we show that b-glucuronidase from four
different sources, including human neutrophils, is able to deconjugate flavonoid glucuronides and non-flavo-
noid substrates at fairly similar kinetic rates. At inflammatory sites in vivo the pH, neutrophil and flavonoid
glucuronide concentrations seem favorable for deconjugation. However, it remains to be confirmed whether
this is actually the case.
Keywords: b-glucuronidase; deconjugation; flavonoids; quercetin; inflammation; neutrophils; enzyme
kinetics; metabolism
Introduction
Epidemiological and animal experimental studies sug-
gest that phenolic compounds such as flavonoids, present
in substantial amounts in our daily diet,1,2) beneficially af-
fect human health.3,4) In vitro studies provide a wide array
of potential mechanisms through which these com-
pounds may act.5) Virtually all of these mechanistic stu-
dies were performed with unconjugated flavonoids, so-
called aglycones. A key issue that has been largely
neglected thus far, is that flavonoid aglycones do not cir-
culate in vivo because of extensive phase II metabolism af-
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ter ingestion.6) In the epithelial cells of the intestinal wall
and in liver, flavonoids are rapidly conjugated, primarily
with glucuronic acid, catalyzed by UDP-
glucuronosyltransferase.2,7) Conjugation of bioactive
compounds makes them more water soluble and conse-
quently leads to rapid elimination of the conjugated com-
pounds from the body via the urine. In addition to
facilitating excretion, conjugation has been shown to
decrease bioactivity of flavonoids in in vitro studies.7,8)
Hydrolysis of the glucuronide moiety can be carried
out by mammalian b-glucuronidase (EC 3.2.1.31), an en-
zyme present in high concentrations in the lumen of the
endoplasmic reticulum and in the lysosomal fraction of
cells of most tissues, but particularly the intestine and
liver.9) Deconjugation of flavonoid glucuronides could
lead to prolonged circulation and enhanced bioactivity.
Flavonoid glucuronides are substrates for hepatic b-
glucuronidase. O'Leary et al.10) showed that flavonoid
glucuronides were deconjugated after entering intact
HepG2 cells via an as yet unidentified transporter. Up-
take of flavonoid glucuronides by cell types other than
liver or intestinal cells has not been demonstrated so far
and it is therefore unknown whether glucuronidated
compounds reach intracellular b-glucuronidase of tissues
other than the intestine and liver.
In 2000, Shimoi et al.11) presented the hypothesis that
b-glucuronidase released from neutrophils at inflamma-
tory sites may be able to deconjugate flavonoid
glucuronides. Lysosomal b-glucuronidase is present in
high concentrations in neutrophils and eosinophils.
Upon stimulation, these inflammatory cells release b-
glucuronidase into the extracellular space.12) This could
lead to increased local b-glucuronidase activity at inflam-
matory sites and increased serum b-glucuronidase con-
centrations during inflammation.13) Pre-clinical cancer
studies with glucuronidated prodrugs found drug activa-
tion by b-glucuronidase excreted from neutrophils in
necrotic areas of human pancreatic and lung carcinomas.
This led to increased deposition of the active drug in
tumor xenografts and reduced drug load to normal tis-
sues.14,15) b-Glucuronidase from stimulated neutrophils
has the ability to hydrolyze flavonoid glucuronides in
vitro,13) but the deconjugation kinetics have never been
studied in detail.
The work presented here describes the deconjugation
kinetics of five flavonoid glucuronides, and compares
them to the commercially available non-flavonoid glucu-
ronide substrates 4-methylumbelliferyl-b-D-glucuronide
(4MUglA) and para-nitrophenol-glucuronide (pNPglA). In
addition, we assessed the pH optimum for b-glucuroni-
dase, and compared the activity of human neutrophil b-
glucuronidase to that of human recombinant b-
glucuronidase, b-glucuronidase from the neutrophil-like
tumor cell line PLB-985, and b-glucuronidase from the
mollusk Helix pomatia.
Materials and Methods
Materials: All materials were purchased from Sig-
ma-Aldrich (St. Louis, MO) unless stated otherwise and
were of analytical or HPLC grade, where applicable.
Water was purified with a MilliQ system (Millipore, Wat-
ford, UK).
Enzyme sources: Four sources of b-glucuronidase
were compared. Helix pomatia (type H5, Æ400,000
units/g solid) is commonly used in sample processing to
deconjugate flavonoid glucuronides present in blood
plasma. Helix pomatia H5 is a mixture of enzymes con-
taining b-glucuronidase and sulfatase activity.
Recombinant human b-glucuronidase isolated from
murine fibroblasts was generously provided by Prof. S. R.
Roffler (Institute of Biomedical Sciences, Taipei, Taiwan).
The recombinant human b-glucuronidase was highly
pure, active, and contained normal post-translational
modifications.16)
Finally, cell free extracts of PLB-985 cells and isolated
human blood neutrophils were used as sources of b-
glucuronidase. The human myeloid leukemia cell line
PLB-985 can differentiate into mature neutrophils.
Differentiated PLB-985 cells have been shown to closely
mimic human blood neutrophils in terms of morphology,
degranulation, and oxidative response.17) Cells were cul-
tured in RPMI-1640 culture medium with 10% fetal bo-
vine serum (FBS; Invitrogen), 2% penicillin/streptomycin
(Gibco), and 1% Glutamax (Invitrogen) in a humidified
379C incubator with 5% CO2. Cells were subcultured
twice a week. For differentiation, cells were transferred
to RPMI-1640 medium supplemented with 0.5% N,N-
dimethylformamide, 0.25% FBS, 1% Nutridoma-SP
(Roche), 2% penicillin/streptomycin, and 1% Glutamax,
at a starting concentration of ¿2×105 cells/mL, and
cultured for 6 days. Differentiation was confirmed by
May-Grunwald-Giemsa staining of cytocentrifuged cells
and by their ability to produce superoxide anion and
release b-glucuronidase in response to stimulation with
phorbol 12-myristate 13-acetate (PMA). On day 6, ¿1×
106 viable cells/mL were available for experiments. Hu-
man neutrophils were isolated as described by Gungor et
al‚18) from fresh blood of 5 healthy volunteers (4 females,
1 male; mean age 26.6 yrs, range 24–29 yrs), in accor-
dance with standard procedures at Maastricht University.
To obtain cell free extracts, PLB-985 cells were first
washed with HEPES medium (20 mM HEPES, 132 mM
NaCl, 6 mM KCl, 1 mM MgSO4, 1.2 mM K2HPO4, 1 mM
CaCl2, 5.6 mM glucose, and 0.5% human serum albumin
(Sanquin, Amsterdam, Netherlands), pH 7.4), and then
resuspended in reaction buffer (0.1 M sodium-acetate
buffer pH 4.0; final concentration 7.2×106 cells/mL)
containing Triton X-100 at a final concentration of 0.5%,
whereas isolated neutrophils were directly resuspended
in reaction buffer with Triton X-100 (final concentration
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Fig. 1. Molecular structure of glucuronidated flavonoid
metabolites
R＝H:quercetin-3-glucuronide,R＝CH3: isorhamnetin-3-glucuronide.
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4×106 cells/mL). Cells were vortex mixed and kept on
ice for 10 min. Then, the samples were filtered through a
5-mm acrodisc (Pall, MI) to remove cell debris.
b-Glucuronidase activity of cell-free extracts of both
PLB-985 cells and isolated neutrophils was determined
on each experimental day by assessing the initial rate of
hydrolysis (V0) at 379C with 100 mM 4-methylumbel-
liferyl-b-D-glucuronide (4MUglA) as a substrate, as de-
scribed below. Similar experiments were carried out on
one day in triplicate for Helix pomatia and recombinant
human b-glucuronidase. The release of 1 mM 4-
methylumbelliferyl (4MU) per min under these condi-
tions was considered 1 unit.
Protein contents were determined in 50-mL samples by
the bicinchoninic acid assay with reagents from Pierce
(Rockford, IL), and bovine albumin as a standard.
Substrates: 4MUglA and pNPglA were purchased
from Fluka. Quercetin-3-glucuronide (Q3glA), quercetin-
3?-glucuronide (Q3?glA), quercetin-4?-glucuronide
(Q4?glA), quercetin-7-glucuronide (Q7glA), and 3?-
methylquercetin-3-glucuronide (isorhamnetin-3-
glucuronide, IR3glA) (Fig. 1) were chemically synthe-
sized as described previously.19) Purity of the compounds
was checked by HPLC with UV detection (see assay be-
low) and was À98.5% for all compounds.
Assays for b-glucuronidase activity: To monitor
hydrolysis of the glucuronide moiety, all substrates and
b-glucuronidase sources were dissolved in reaction
buffer (0.1 M sodium-acetate buffer pH 4.0). All assays
were performed in triplicate (4MUglA and pNPglA) or
duplicate (flavonoid glucuronides). Release rates of agly-
cones were quantified by comparison to appropriate stan-
dard curves for each substrate, and expressed as mmol
min－1mg－1 protein. Standard curves were all linear in
the range tested (R2À0.995). Km and apparent Vmax were
calculated with the method of Lineweaver and Burk.20)
Initial rates of hydrolysis obtained at low substrate con-
centrations were not included in the Lineweaver-Burk
plots if they clearly deteriorated the fit of the regression
line. Eadie-Hofstee plots, which are less sensitive to varia-
tions in V0 at low concentrations, were constructed to
verify the results. In all cases, the Eadie-Hofstee plots
gave results similar to those obtained with Lineweaver-
Burk plots. The rate constant (k) of the reaction at low
substrate concentrations was determined as the slope of
the initial linear part of the Michaelis-Menten curve, and
by calculating the ratio of Vmax/Km.
We used a modified 4MUglA assay to determine b-
glucuronidase activity. Hydrolysis of 4MUglA was fol-
lowed fluorometrically in a thermostated platereader
(Spectra max m2, MDS, CA) at 379C and 320/460 nm
excitation/emission wavelengths. Usually, 4MUglA
hydrolysis assays monitor fluorescence of 4MU at
360/460 nm excitation/emission wavelengths after stop-
ping the reaction with glycine buffer pH 10.5. However,
to make kinetic measurements without stopping the reac-
tion, detection at 320/460 nm proved more sensitive.
Since only the deconjugated product fluoresces, the
hydrolysis can be followed continuously for 30 min
without stopping the reaction. To 20 mL of b-glucuroni-
dase solution, 40 mL of 4MUglA were added at concen-
trations between 0.45 and 2000 mM. The protein con-
centration of the b-glucuronidase solution was 14.7 mg/L
for Helix pomatia, 1.1 mg/L for recombinant human b-
glucuronidase, 160.2 mg/L for PLB-985 cell lysates, and
320.1 mg/L for the isolated human neutrophil lysates.
pNPglA deconjugation was assessed in the same
platereader by absorbance measurement at 405 nm.
pNPglA (40 mL) at concentrations between 7.8 and 4000
mM was incubated with 20 mL of b-glucuronidase solu-
tion at 379C. The reaction was stopped by adding 100
mL 0.5 M glycine buffer pH 10.5 at t＝0, 5, 10, 20, 30,
40, 50, and 60 min.
Hydrolysis of the flavonoid glucuronides was moni-
tored after isocratic HPLC separation by UV detection at
375 nm for the QglA's and IR3glA. For each concentra-
tion and time point tested, 40 mL of substrate (at concen-
trations of 6.25, 12.5, 25, 50, 100, and 200 mM) was in-
cubated with 20 mL of b-glucuronidase solution at 379C.
The reaction was stopped at t＝0, 5, 10, 20, 30, and 40
min by adding 30 mL of ACN/phosphoric acid (80/20%
v/v). Detection of the flavonoid glucuronides and agly-
cones was achieved by injecting 25 mL of sample onto a
Chromolith RP 18e column (100×4.6 mm; Merck, Dar-
mstadt, Germany) at 309C, in an HP1100 HPLC system
(Agilent, Palo Alto, CA). The eluent consisting of
ACN/water/TFA (30/70/0.1% v/v/v) was run at 2.5
mL/min, and total run time for each sample was 3.5 min.
D-Saccharic acid-1,4-lactone (final concentration 4.4
mM) a b-glucuronidase inhibitor, was added to control
incubations of all substrates to check whether inhibition
of the enzyme completely blocked the hydrolysis of all
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Table 1. Kinetic constants for the hydrolysis of flavonoid,
para-nitrophenol, and 4-methylumbelliferyl glucuronides by
Helix pomatia b-glucuronidase, recombinant human b-
glucuronidase, and by b-glucuronidase from human neu-
trophil and PLB–985 neutrophil-like cell line lysates at pH 4
Kinetic constants per mg or g protein Kinetic constants per Ua
Vmax Km k Vmax k
mmolmin－1･mg－1 mM min－1･(g/L)－1 mmol･min－1･U－1 min－1･(U/L)－1
Helix pomatia
pNPglA 0.274 197 1.242 2.794 0.013
4MUglA 0.097 37 2.733 0.988 0.028
Q3?glA 0.168 111 1.284 1.707 0.013
Q4?glA 0.116 22 2.969 1.185 0.030
Q3glA 0.157 183 0.831 1.598 0.008
Q7glA 0.118 129 0.848 1.206 0.009
IR3glA 0.072 71 0.898 0.735 0.009
Recombinant human
pNPglA 7.118 981 4.962 3.269 0.002
4MUglA 4.336 207 23.723 1.991 0.011
Q3?glA 3.362 94 33.766 1.544 0.016
Q4?glA 1.854 93 14.205 0.852 0.007
Q3glA 1.880 33 66.059 0.863 0.030
Q7glA 8.356 151 57.562 3.837 0.026
IR3glA 52.283 459 104.920 24.012 0.048
PLB-985 cell line lysate
pNPglA 0.005 695 0.006 ND ND
4MUglA 0.002 120 0.011 ND ND
Q3?glA — — 0.019 — 0.060
Q4?glA 0.005 133 0.033 5.401 0.035
Q3glA 0.001 63 0.019 2.508 0.033
Q7glA 0.006 290 0.018 3.741 0.011
IR3glA 0.011 344 0.030 6.980 0.020
Isolated human neutrophil lysate
pNPglA 0.031 66 0.428 ND ND
4MUglA 0.002 121 0.012 ND ND
Q3?glA 0.007 217 0.041 4.040 0.025
Q4?glA 0.008 52 0.150 3.124 0.062
Q3glA 0.005 199 0.027 1.792 0.010
Q7glA 0.011 311 0.037 6.190 0.021
IR3glA 0.015 244 0.056 8.777 0.032
4MUglA, 4-methylumbelliferyl-b-D-glucuronide; pNPglA, para-nitrophenol-
glucuronide; Q3glA, quercetin-3-glucuronide; Q3?glA, quercetin-3?-
glucuronide; Q4?glA, quercetin-4?-glucuronide; Q7glA, quercetin-7-
glucuronide; IR3glA, isorhamnetin-3-glucuronide; ND, not determined.
aOne unit (U) is defined as the release of 1 mM 4-methylumbelliferyl per min.
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glucuronidated substrates.
pH optimum determination: Incubations were
carried out in triplicate at different pH values to deter-
mine the effects of pH on b-glucuronidase activity with
100 mM 4MUglA and pNPglA as substrates. Instead of
reaction buffer, 0.1 M sodium-acetate buffer of pH 3.5,
4.0, 4.5, 5.0, 5.5, and 6.0, or 0.1 M potassium-phosphate
buffer of pH 6.0, 6.5, 7.0, and 7.2 was used. At each pH
a standard curve of 4MU and pNP was constructed to
correct for pH effects on the measurement of the reac-
tion product. 4MU release was determined continuously
for 30 min and V0 at each pH was plotted. Release of
pNP was measured at 60 min (Helix pomatia and human
recombinant b-glucuronidase) or 120 min (cell line and
isolated neutrophil b-glucuronidase). At these time
points, deconjugation rates were constant. Otherwise,
reaction conditions were the same as in the kinetic ex-
periments.
Control experiments were conducted to check
whether proteases possibly present in the cell-free ex-
tract of PLB-985 cells influences the b-glucuronidase ac-
tivity by breaking down the enzyme. b-Glucuronidase ac-
tivity was assessed in duplicate with 4MUglA as a sub-
strate at concentrations between 3.9 and 1000 mM at pH
4 and 7.2, after preincubation of the intact cells for 10
min with 5.7 mM diisopropylfluorophosphate, and after
addition of 10 mL of protease inhibitor cocktail (Sigma
P8340) to 990 mL of the cell lysate.
Results
The deconjugation of five glucuronidated quercetin
metabolites (Q3?glA, Q4?glA, Q3glA, Q7glA, and IR3g-
lA) and two commercially available glucuronidated sub-
strates (pNPglA, and 4MUglA) by b-glucuronidase from
four different sources was studied to establish enzyme ki-
netic parameters. All substrate-enzyme combinations
tested exhibited first-order kinetics.
Estimated Vmax, Km, and k at pH 4 for all sources and
substrates tested are presented in Table 1. Because of
the limited availability of the quercetin glucuronides, we
were not able to determine hydrolysis rates above final
concentrations of 140 mM, which were sometimes lower
than the Km estimated based on these experiments. This
means that there is a substantial degree of uncertainty in
some Km and Vmax values presented in Table 1. The
hydrolyses rates at low substrate concentrations (k), also
presented in Table 1, were not affected by this. Km,
which is independent of the amount of protein present
during incubation, ranged 44-fold from 22 mM for Q4?-
glA with Helix pomatia, to 981 mM for pNPglA with
recombinant human b-glucuronidase. The range in Vmax
and k values was much higher, À52 000-fold and À
17 000-fold, respectively, mainly because these values
are expressed relative to the total protein content, and
two of the b-glucuronidase sources used were cell lysates
containing little b-glucuronidase compared to total pro-
tein. The average protein concentrations present during
incubation were 14.7 mg/L for Helix pomatia, 1.1 mg/L
for recombinant human b-glucuronidase, 160.2 mg/L for
PLB-985 cell lysates, and 320.1 mg/L for the isolated hu-
man neutrophil lysates. Overall, the Vmax and k values
were highest for recombinant b-glucuronidase, lower for
Helix pomatia b-glucuronidase, and lowest but compara-
ble for the cell lysates, reflecting the proportion of b-
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Fig. 2. Effects of pH on hydrolysis of para-nitrophenol
glucuronide (A) and 4-methylumbelliferyl glucuronide (B) by
Helix pomatia b-glucuronidase, recombinant human b-
glucuronidase, and by b-glucuronidase from human neu-
trophil and PLB-985 neutrophil-like cell line lysates
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glucuronidase in the total protein content. When Vmax
and k were expressed per unit (with 1 unit defined as the
release of 1 mM 4MU per min), the kinetic constants for
all enzyme sources were of the same order of magnitude
(Table 1).
Compared to the other substrates tested, pNPglA had
a relatively high Km, ranking highest for 3 out of 4 en-
zyme sources. pNPglA combined this relatively high Km
with a relatively high Vmax for each enzyme source. Its
Vmax ranked highest for Helix pomatia and isolated neu-
trophils, and third for the recombinant human b-
glucuronidase and the human cell line, reaching its
highest hydrolysis rate with recombinant human b-
glucuronidase at 7.1 mmolmin－1mg－1 protein. Vmax
and Km values for the four quercetin glucuronides were
very similar when each source of enzyme was considered
individually. The difference between the highest and
lowest Vmax ranged from 1.4- to 6-fold for the four quer-
cetin glucuronides, whereas the highest versus lowest Km
differed 5- to 8-fold. Thus, the position of the glucuronic
acid on the quercetin molecule did not seem to influence
Vmax nor the Km considerably. Vmax and Km values for the
hydrolysis of 4MUglA were of the same order of magni-
tude as those for the quercetin glucuronides. Methylation
of Q3glA at the 3?-position, which yields IR3glA, en-
hanced the Vmax compared to its unmethylated counter-
part for human b-glucuronidase from different sources (3
to 28-fold), but decreased the Vmax for the mollusk b-
glucuronidase 2-fold. At the same time methylation
resulted in a 1.2 to 14-fold higher Km for the human b-
glucuronidase sources, but a 3-fold lower Km for the mol-
lusk b-glucuronidase. The resulting k values for IR3glA
compared to Q3glA were similar for the mollusk b-
glucuronidase, but approximately 2-fold higher for all
types of human b-glucuronidase.
Estimates of k values obtained by dividing the Vmax by
Km (data not shown) were in good agreement with those
obtained from the slope of the initial linear part of the
Michaelis-Menten plot, provided that the slope was deter-
mined at substrate concentrations below ¿10% of the
Km. On only 3 occasions k was determined at higher con-
centrations; in those cases the slope underestimated the
calculated k by 29–43%, as expected.
The b-glucuronidase inhibitor D-saccharic acid-1,4-lac-
tone completely blocked the production of aglycones
from the glucuronides tested (data not shown). Control
incubations with cell-free extract of the PLB-985 cells
conducted in the presence of protease inhibitors at pH 4
and 7.2 gave results similar to those conducted without
protease inhibitors. At pH 4, Vmax was 76% with protease
inhibitor cocktail and 63% with diisopropyl-
fluorophosphate compared to no inhibitor, indicating
that there was no breakdown of b-glucuronidase by pro-
teases under the incubation conditions used, but rather
that the protease inhibitors reduced enzyme activity. At
pH 7.2, no activity was found either with or without inhi-
bitors.
Experiments to determine the pH optimum of b-
glucuronidase were carried out with 4MUglA and pNPg-
lA. The optimum pH for hydrolysis of 4MUglA was 3.5
to 4 (Fig. 2), with appreciable hydrolysis activities up to
a pH of 5.5. For hydrolysis of pNPglA the optimum pH
seemed slightly higher and was more variable between
the enzyme sources tested. For Helix pomatia b-
glucuronidase the optimum was again 3.5, but for the
other enzyme sources the optimum pH was between 4.5
and 5. At near-physiological pH 7.2, b-glucuronidase ac-
tivity was low. The type of buffer used at pH 6 (0.1 M
sodium-acetate or potassium-phosphate buffer) did not
substantially influence activity, except for recombinant
b-glucuronidase with pNP, where the activity was 29%
lower when the phosphate buffer was used.
Discussion
We have shown that b-glucuronidase from four differ-
ent sources has the capacity to deconjugate five flavonoid
metabolites (Q3?glA, Q4?glA, Q3glA, Q7glA, and IR3g-
lA) and two non-flavonoid glucuronidated substrates
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(pNPglA and 4MUglA). The kinetics of hydrolysis of all
substrates tested were remarkably similar, suggesting that
b-glucuronidase has broad specificity. The different en-
zyme sources exhibited Vmax and reaction rate constants
k that were of the same order of magnitude for each sub-
strate when expressed per unit enzyme activity. The
differences in kinetic constants were relatively large
when expressed per mg or g of protein, because the
proportion of b-glucuronidase to total protein was high
for the pure enzyme (recombinant human b-glucuroni-
dase) and the purified extract (Helix pomatia), but low for
the cell lysates (PLB-985 neutrophil-like myeloid cell line,
and isolated human neutrophils).
Cell-free extracts from the human liver, small intes-
tine, placenta, feces, neutrophils, and several human cell
lines (liver, endothelial cells, intestine, lung fibroblast)
have previously been shown to possess b-glucuronidase
activity towards pNPglA and/or 4MUglA.10,21–24) For
4MUglA, Km values reported were 330 mM21) for human
neutrophils, and ¿50 mM for placental b-glucuroni-
dase.22) O'Leary et al.24) presented kinetic constants at pH
7.2 for the hydrolysis of a mixture of several flavonoid
glucuronides and pNPglA by human recombinant b-
glucuronidase isolated from COS-7 cells. Km values
reported by them are of the same order of magnitude as
in our study: 1400, 48, 167, and 237 mM for pNPglA,
Q4?glA, Q3glA, and Q7glA, respectively, but no data
were reported for Q3?glA or IRglA. Whereas in our ex-
periments, the activity of all b-glucuronidase sources
tested was low at pH 7.2, O'Leary et al.24) reported rela-
tively high Vmax values at pH 7.2, of similar magnitude as
we found at pH 4. In our study at pH 4 the Vmax for hu-
man recombinant b-glucuronidase ranged from 1.9 to
8.4 mmolmin－1mg－1 protein for the three quercetin
glucuronides and pNPglA, whereas in the study by O'Lea-
ry et al. at pH 7.2 the apparent activity for these com-
pounds ranged from 0.5 to 3.4 mmolmin－1mg－1 pro-
tein,24) only slightly lower. It is unclear why O'Leary et al.
found such high activity at physiological pH.
The optimum pH for hydrolysis varied with substrate
and enzyme source. For Helix pomatia the pH optimum
may be even lower than the lowest value tested, which
was pH 3.5. To the best of our knowledge, no data have
been published on the pH optimum for Helix pomatia b-
glucuronidase, although it is generally used at pH 4–5
during sample preparation for the determination of agly-
cone contents in plasma. For the human b-glucuronidase
sources tested, we found an optimum pH between 3.5
and 5. In general, data reported in the literature agree
with our values, although no identical substrate-enzyme
source combinations have been tested previously. An ear-
ly study on rat neutrophil b-glucuronidase reported a pH
optimum of ¿5 when phenolphtalein glucuronide was
used as a substrate.25) Human recombinant b-glucuroni-
dase had higher activity at pH 5.5 compared to pH 7 and
7.4 when N-hydroxy-diacetylbenzidine glucuronide was
used as a substrate.26) Human b-glucuronidase derived
from placenta,22) lung tumor tissue,27) or synovial fluid28)
all exhibited optima between pH 3.5 and 5. Contractor
and Shane22) were the only ones to determine the optimal
pH of 4MUglA hydrolysis by b-glucuronidase (from
placenta), which they found to be 3. This agrees with the
relatively low pH we found to be optimal for 4MUglA
compared to pNPglA.
So far, only one b-glucuronidase isoenzyme has been
identified, although differences in the degree of glycosy-
lation that affect its activity have been observed. Both
microsomal and lysosomal b-glucuronidase are derived
from the same gene.9,24) Early studies reported on a
separate placental isoenzyme, with properties different
from the enzyme found in plasma.22) The placental isoen-
zyme was heat labile and had lower specific activity.
However, these findings have not been confirmed in later
studies. Next to b-glucuronidase, the mammalian en-
zyme UDP-glucuronyltransferase (EC 2.4.1.17) reported-
ly has the capacity to deconjugate glucuronic acid
metabolites. However, the b-glucuronidase activity of
UDP-glucuronyltransferase is UDP-dependent, and is, in
contrast to the activity of b-glucuronidase, not inhibited
by D-saccharic acid-1,4-lactone.29) The b-glucuronidase
activity in our experiments was completely inhibited by
D-saccharic acid-1,4-lactone, suggesting that no residual
UDP-glucuronyltransferase contributed to the hydrolysis
rates observed. UDP-glucuronyltransferase is present in
high concentrations in the liver and other metabolizing
organs. If true, the b-glucuronidase activity of UDP-
glucuronyltransferase may disqualify the results reported
from studies with tissue cell-free extracts or microsomal
fractions in which inhibition of the reaction was not
checked by adding the specific b-glucuronidase inhibitor
D-saccharic acid-1,4-lactone.
Several authors have shown that b-glucuronidase is
remarkably stable and resistant to proteolytic break-
down. Wiener et al.25) reported that the enzyme activity
of human neutrophil b-glucuronidase lysates remained
constant for up to 2 h, which was considered indicative
for the absence of enzyme breakdown.25) We found no
change in reaction rates when protease inhibitors were
added. This indicates that proteolytic breakdown of b-
glucuronidase did not affect our data. b-Glucuronidase is
also remarkably insensitive to heat and pH inactivation.
Mouse kidney b-glucuronidase was stable between pH 4
and 11 for at least 30 min, and at temperatures up to
559C for at least 10 min.30)
Differentiated PLB-985 cells were previously shown to
mimic mature neutrophils in terms of morphology, ox-
idative response, and functional degranulation of my-
eloperoxidase-negative granules and secretory vesicles.17)
b-Glucuronidase is present in the azurophil or primary
granules, which are packaged with acidic hydrolases, and
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are the first granules formed during granulopoiesis.31)
Our results demonstrate that b-glucuronidase from
differentiated PLB-985 cells has kinetic constants for the
hydrolysis of glucuronidated substrates that are similar to
those obtained with isolated human neutrophils. This
suggests that PLB-985 cells are a useful model system for
investigating b-glucuronidase from human neutrophils.
The acute inflammatory host response is characterized
by recruitment of neutrophils into inflamed tissue within
minutes to hours. During subsequent migration through
interstitial tissues, azurophil granules undergo partial ex-
ocytosis, resulting in the release of a host of matrix-
degrading and other enzymes, including b-glucuronidase,
into the extracellular space.31) Whether b-glucuronidase
enhances the bioactivity of flavonoid glucuronides at in-
flammatory sites will depend strongly upon local neu-
trophil concentrations, flavonoid glucuronide concentra-
tions, and pH. We conducted our incubations with lysed
cells at concentrations between 1.3 and 2.5×106
cells/mL, final flavonoid glucuronide concentrations be-
tween 4.2 and 133 mM, and optimum pH for b-
glucuronidase was determined to be between pH 3.5 and
5, depending on the enzyme source and substrate.
Animal models of inflammation show that neutrophil
concentrations in subcutaneous pouches or sponges can
by far exceed the concentrations used in our experi-
ments, and reach up to 135×106 cells/mL.25,32) However,
human studies with milder inflammation have generally
found lower neutrophil counts. For example, neutrophil
concentrations in bronchoalveolar lavage fluid were
¿75×104 cells/mL after corn dust inhalation,33) ¿12×
105 cell/mL after LPS inhalation,34) and up to 5.9×104
cells/mL in smokers.35) Plasma concentrations of flavo-
noid glucuronides are typically below 1 mM.36,37) No evi-
dence is available so far that concentrations approaching
Km are attained anywhere in the mammalian body, except
for excretory fluids like bile, in which concentrations in
rats were found to approach 350 mM after intestinal per-
fusion with 50 mM quercetin for 30 min.38,39) Thus, reac-
tion rates in vivo will not be saturated and the deconjuga-
tion rate is best decribed by the rate constant k. This
means that under the conditions used with the isolated
human neutrophil lysate the half-life of quercetin
glucuronides ranges from 15 (Q4?glA) to 80 (Q3glA) min
at pH 4. To our knowledge, no information is available
on flavonoid glucuronide concentrations at inflammatory
sites. The notion of decrease in tissue pH during inflam-
mation has been reported for different types of inflamed
tissue, including atherosclerotic plaques,40) certain solid
tumors,27) and arthritic joints,41) as well as in animal
models of subcutaneous inflammation.32) However, ac-
curate determination of tissue pH remains extremely
difficult, and reported values vary widely. Moreover, the
observed decrease in pH during inflammation is usually
only modest, with lowest reported values of approxi-
mately 6.27,32) Although we found the activity of b-
glucuronidase to be much lower at higher pH values, at
pH 6 approximately 10–20% of the maximum activity at
pH 4, deconjugation may still occur in vivo. A deconjuga-
tion rate of only 10% of the maximum, would give reac-
tion half-lifes ranging from 150 (Q4?glA) to 800 (Q3glA)
min. The elimination half-life of quercetin from blood af-
ter ingestion of a single dose of quercetin glucosides is
approximately 18 h,42) suggesting that even at these lower
hydrolysis rates, substantial deconjugation may occur.
Thus, in vivo conditions under which b-glucuronidase
from neutrophils enhance the bioactivity of flavonoid
glucuronides at inflammatory sites seem achievable.
However, it remains to be confirmed whether this is ac-
tually the case.
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